Pricing Log in Create free account
Friday 6 November 2026 Export BIIB’s income statement to Excel — free account

Biogen Inc.

BIIB Healthcare Drug Manufacturers General

Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024.

Revenue
+10.6%
EPS
−104.4%
Free cash flow
−69.3%
Total debt
+16.0%

Quarter to September 2026, against a year earlier

248.32 4.39 +1.80%
Market cap
$36.1B
P/E
104×
Fwd P/E
47.4×
Dividend yield
—
F-score
4/9
Altman Z
3.13
Beneish M
−2.67
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Biogen Inc. (BIIB) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Biogen Inc. (BIIB) trades at a EV/EBITDA of 18.4×. Over the past ten years it has ranged from 5.6× (October 2019) to 23.9× (March 2015); the current reading is higher than 97% of that period. That is above the Drug Manufacturers General industry median of 14.8× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 9.6× 24.17%
FY2024 7.8× (62.73%)
FY2023 20.8× 109.06%
FY2022 9.9× 2.95%
FY2021 9.7× 20.31%
FY2020 8.0× 11.77%
FY2019 7.2× (26.64%)
FY2018 9.8× (14.10%)
FY2017 11.4× 8.59%
FY2016 10.5× (21.82%)

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 17.2× 16.92%
Jun 2026 14.7× 53.78%
Mar 2026 9.6× (0.61%)
Dec 2025 9.6× 33.14%
43 more quarters

Against its own ten years

Low 5.6× High 23.9×
Ten-year median 10.3×
Current reading's percentile 97

EV/EBITDA against peers

Company EV/EBITDA
NVO Novo Nordisk A/S compare 7.3×
GSK GSK PLC Sponsored ADR compare 10.6×
PFE Pfizer Inc. compare 10.9×
BMY Bristol Myers Squibb Company compare 11.3×
SNY Sanofi compare 11.4×
AZN AstraZeneca PLC compare 14.8×
AMGN Amgen Inc. compare 17.6×
BIIB Biogen Inc. 18.4×
GILD Gilead Sciences, Inc. compare 505×
Drug Manufacturers General industry median 14.8×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on BIIB